` AGY (Allergy Therapeutics PLC) vs FTSE All Share Index Comparison - Alpha Spread

AGY
vs
F
FTSE All Share Index

Over the past 12 months, AGY has significantly outperformed FTSE All Share Index, delivering a return of +60% compared to the FTSE All Share Index's 0% growth.

Stocks Performance
AGY vs FTSE All Share Index

Loading
AGY
FTSE All Share Index
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
AGY vs FTSE All Share Index

Performance Gap Between AGY and ASX
HIDDEN
Show

Performance By Year
AGY vs FTSE All Share Index

Loading
AGY
FTSE All Share Index
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Allergy Therapeutics PLC vs Peers

FTSE All Share Index
AGY
LLY
JNJ
ROG
AZN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Allergy Therapeutics PLC
Glance View

Market Cap
629.5m GBX
Industry
Pharmaceuticals

Allergy Therapeutics Plc is a biotechnology company. The company is headquartered in Worthing, West Sussex and currently employs 601 full-time employees. The company went IPO on 2004-10-11. The firm is focused on the treatment and diagnosis of allergic disorders, including immunotherapy vaccines. Its segments include Central Europe, which include segments, such as Germany, Austria, Switzerland and the Netherlands; Southern Europe, which includes Italy, Spain and Other; the United Kingdom, and Rest of World. The company sells both injectable and sublingual allergen-specific immunotherapies. Its pipeline candidates include Grass MATA MPL, Birch MATA MPL, Ragweed MATA MPL, Trees MATA MPL and Peanut SCIT. Its vaccine candidates outside allergy include disease areas, including cancer, asthma, atopic dermatitis and psoriasis. Its products include Pollinex, Pollinex Quattro, Oralvac, Acarovac Plus, Venomil, VLP Peanut and ImmunoBON.

AGY Intrinsic Value
HIDDEN
Show
Back to Top